{"id":25434,"date":"2024-07-15T10:41:28","date_gmt":"2024-07-15T08:41:28","guid":{"rendered":"https:\/\/ggba.swiss\/vanarix-raises-chf-4-million-to-advance-cartilage-regeneration\/"},"modified":"2024-07-15T10:43:42","modified_gmt":"2024-07-15T08:43:42","slug":"vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/","title":{"rendered":"Vanarix l\u00e8ve CHF 4 millions en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage"},"content":{"rendered":"\n<p>Fond\u00e9e en 2018, <a href=\"https:\/\/www.vanarix-cartilage-regeneration.ch\/\">Vanarix<\/a> est une start-up lausannoise sp\u00e9cialis\u00e9e dans la m\u00e9decine r\u00e9g\u00e9n\u00e9rative, avec un accent mis sur la r\u00e9g\u00e9n\u00e9ration du cartilage articulaire. Malgr\u00e9 sa petite \u00e9quipe de trois personnes, la soci\u00e9t\u00e9 a franchi des \u00e9tapes importantes, notamment en levant CHF 4 millions aupr\u00e8s d&rsquo;investisseurs priv\u00e9s pour financer de nouveaux essais cliniques et la mise en \u0153uvre de la fabrication automatis\u00e9e de ses <a href=\"https:\/\/www.vanarix-cartilage-regeneration.ch\/science-8-cartibeadse-geneve-suisse.php\">Cartibeads<\/a>.<\/p>\n\n\n\n<p>Les l\u00e9sions du cartilage, souvent caus\u00e9es par des traumatismes r\u00e9p\u00e9titifs, entra\u00eenent des douleurs et des handicaps et peuvent \u00e9voluer vers l&rsquo;arthrose, une affection qui touche plus de 300 millions de personnes dans le monde. Vanarix rel\u00e8ve ce d\u00e9fi gr\u00e2ce \u00e0 ses billes de cartilage brevet\u00e9es, les premiers implants en forme de billes issus de la bio-ing\u00e9nierie et con\u00e7us pour r\u00e9g\u00e9n\u00e9rer le cartilage endommag\u00e9. Les Cartibeads sont con\u00e7us pour traiter les l\u00e9sions focales et l&rsquo;arthrose pr\u00e9coce en imitant les propri\u00e9t\u00e9s hyalines de haute qualit\u00e9 du cartilage articulaire natif.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Les Cartibeads, une perc\u00e9e dans la r\u00e9g\u00e9n\u00e9ration du cartilage<\/h4>\n\n\n\n<p>Les donn\u00e9es pr\u00e9cliniques ont d\u00e9montr\u00e9 la s\u00e9curit\u00e9 et l&rsquo;efficacit\u00e9 des Cartibeads dans le traitement des l\u00e9sions focales du genou. Les Cartibeads de premi\u00e8re g\u00e9n\u00e9ration de Vanarix ont \u00e9t\u00e9 implant\u00e9s chez 10 patients, avec des am\u00e9liorations significatives des scores de douleur observ\u00e9es chez cinq patients apr\u00e8s six mois. La deuxi\u00e8me g\u00e9n\u00e9ration, les Cartibeads allog\u00e9niques, a montr\u00e9 des r\u00e9sultats prometteurs dans des \u00e9tudes pr\u00e9cliniques sur des miniporcs et dans une \u00e9tude clinique sur de jeunes chevaux atteints d&rsquo;ost\u00e9ochondrite diss\u00e9quante, avec une bonne int\u00e9gration et aucun signe d&rsquo;inflammation ou de rejet.<\/p>\n\n\n\n<p>Suite \u00e0 ces r\u00e9sultats positifs, Swissmedic a autoris\u00e9 Vanarix \u00e0 lancer de nouveaux essais cliniques de phase I\/IIa avec des Cartibeads allog\u00e9niques. Les deux premiers patients seront transplant\u00e9s \u00e0 l&rsquo;h\u00f4pital de Lugano, et d&rsquo;autres patients seront recrut\u00e9s aux HUG, \u00e0 Hirslanden\/La Colline et \u00e0 Balgrist\/Zurich.<\/p>\n\n\n\n<p>Ce nouveau financement et l&rsquo;approbation de l&rsquo;essai clinique constituent une \u00e9tape importante pour Vanarix. L&rsquo;entreprise a pour objectif de commercialiser les Cartibeads dans les trois prochaines ann\u00e9es et pr\u00e9voit de d\u00e9velopper des installations pour une production \u00e0 grande \u00e9chelle et \u00e0 faible co\u00fbt. L&rsquo;approche innovante de la start-up en mati\u00e8re de r\u00e9g\u00e9n\u00e9ration du cartilage promet d&rsquo;am\u00e9liorer la vie des patients et de r\u00e9pondre \u00e0 un important besoin m\u00e9dical non satisfait.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bas\u00e9e au Biop\u00f4le, la start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads. <\/p>\n","protected":false},"author":6,"featured_media":25431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1163,1141],"class_list":["post-25434","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage<\/title>\n<meta name=\"description\" content=\"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage\" \/>\n<meta property=\"og:description\" content=\"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-15T08:41:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-15T08:43:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Vanarix l\u00e8ve CHF 4 millions en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage\",\"datePublished\":\"2024-07-15T08:41:28+00:00\",\"dateModified\":\"2024-07-15T08:43:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\"},\"wordCount\":455,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\",\"name\":\"Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg\",\"datePublished\":\"2024-07-15T08:41:28+00:00\",\"dateModified\":\"2024-07-15T08:43:42+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Les Cartibeads de Vanarix sont des implants en forme de billes issus de la bio-ing\u00e9nierie et con\u00e7us pour r\u00e9g\u00e9n\u00e9rer le cartilage articulaire endommag\u00e9. | \u00a9 Vanarix\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanarix l\u00e8ve CHF 4 millions en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage","description":"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/","og_locale":"fr_FR","og_type":"article","og_title":"Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage","og_description":"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.","og_url":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-07-15T08:41:28+00:00","article_modified_time":"2024-07-15T08:43:42+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Vanarix l\u00e8ve CHF 4 millions en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage","datePublished":"2024-07-15T08:41:28+00:00","dateModified":"2024-07-15T08:43:42+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/"},"wordCount":455,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg","keywords":["Financing","Healthcare","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/","url":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/","name":"Vanarix l\u00e8ve CHF 4M en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg","datePublished":"2024-07-15T08:41:28+00:00","dateModified":"2024-07-15T08:43:42+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La start-up Vanarix a lev\u00e9 CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/07\/Vanarix-Knee-Arthrosis-1180x811-1.jpg","width":1180,"height":811,"caption":"Les Cartibeads de Vanarix sont des implants en forme de billes issus de la bio-ing\u00e9nierie et con\u00e7us pour r\u00e9g\u00e9n\u00e9rer le cartilage articulaire endommag\u00e9. | \u00a9 Vanarix"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/vanarix-leve-chf-4-millions-en-faveur-de-la-regeneration-du-cartilage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Vanarix l\u00e8ve CHF 4 millions en faveur de la r\u00e9g\u00e9n\u00e9ration du cartilage"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/25434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=25434"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/25434\/revisions"}],"predecessor-version":[{"id":25436,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/25434\/revisions\/25436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/25431"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=25434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=25434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=25434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}